Financials
Financial year 2025
DIALEX BIOMEDICA from Bilzen-Hoeselt, company number BE0427436636, closed financial year 2025 with a result of € 2.6 million after tax. For that financial year DIALEX BIOMEDICA recorded a gross margin of € 4 million and equity of € 2.9 million. Compared with financial year 2024, the result moved from € 2.3 million to € 2.6 million. Profitable, and profit is growing. The buffer shrank hard: equity is 57 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.
€ 2.9 million
▼ 57% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.6 million
▲ 16% vs 2024
Profit after tax over the fiscal year.
€ 1.8 million
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 6.5 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
6.6
Average over the fiscal year, from the social balance sheet.
€ 546,397
▲ 11% vs 2024
€ 82,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 15,764
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 236,301
▼ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 302,488
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 10,002,584 | € 9,898,321 | € 9,899,485 | - | |
| Gross margin | - | - | - | € 3,990,660 | |
| Profit after taxes | € 1,979,979 | € 2,139,469 | € 2,282,368 | € 2,636,886 | ▲ 16% |
| Equity | € 6,342,263 | € 6,481,732 | € 6,764,099 | € 2,900,985 | ▼ 57% |
| Total debts | € 479,600 | € 881,579 | € 719,639 | € 5,073,097 | ▲ € 4.4 million |
| Cash | € 1,563,369 | € 1,353,736 | € 1,690,217 | € 1,787,645 | ▲ 6% |
| Land & buildings | € 372,980 | € 646,097 | € 673,459 | € 601,336 | ▼ 11% |
| Retained profit | € 6,280,263 | € 6,419,732 | € 6,702,099 | € 2,838,985 | ▼ 58% |
| Dividend | € 2,000,000 | € 2,000,000 | € 2,000,000 | € 6,500,000 | ▲ 225% |
| Balance sheet total | € 6,821,863 | € 7,363,311 | € 7,483,738 | € 7,974,082 | ▲ 7% |
| Employees (FTE) | 8.2 | 6.8 | 6.6 | 6.6 |
Key figures of DIALEX BIOMEDICA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to DIALEX BIOMEDICA?
What happened at DIALEX BIOMEDICA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Florent Barthels stepped down as director. NBB
- 1821 BV stepped down as director. NBB
- Dialex Biomedica Sales BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.6 million (▲ 16% vs 2024). Source: NBB ↗
- Florent Barthels became a director. NBB
- Dialex Biomedica Sales BV became a director. NBB
- 1821 BV became a director. NBB
- New establishment in Bilzen-Hoeselt. KBO
In short
From € 2 million profit in 2022 to € 2.6 million profit in 2025.
Paid € 3 million in corporate taxes since 2022.
Best year ever: 2025, with € 2.6 million profit.
On average € 604,600 of value added per employee in 2025.
A new publication or filing at DIALEX BIOMEDICA? We notify you, reason included.
Follow DIALEX BIOMEDICADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Dialex Biomedica Sales (99.8%), Florent Barthels (0.1%) and Marie-Rose Neesen (0.1%).
Directors
According to the 2025 annual accounts
Florent Barthels
Director
Owns 0.1% directly
since 2019 · until 2029
Director · represented by Jochems ALEXANDER
since 2018 · until 2029
Managing director · represented by Barthels MICHAËL
since 2019 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Caetsbeekstraat 1
3740 Bilzen-Hoeselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
UPCLOUD, FI
Website info
Features
Security
Details
- Company number
- 0427.436.636
- VAT number
- BE 0427.436.636
- Registered office
- Caetsbeekstraat 1, 3740 Bilzen-Hoeselt
- Names & denominations
- DIALEX BIOMEDICA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 1985
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- dialexbiomedica.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels